title: Piramal Imaging.
abstract: Piramal Imaging, a division of Piramal Enterprises Ltd, is a global radiopharmaceutical company that is actively developing novel PET radiotracers for use in molecular imaging. The company focuses on developing innovative products that improve early detection and characterization of chronic and life-threatening diseases, leading to better therapeutic outcomes and improved quality of life.
authors: Piramal Imaging SA, Route de l'Ecole 13, 1753 Matran, Switzerland.|Piramal Imaging GmbH, Tegeler Straße 6-7, 13353 Berlin, Germany.
authors: Ludger
authors: L
authors: Dinkelborg
mesh_terms: D000544:Alzheimer Disease / Q000000981:diagnostic imaging*; D006801:Humans; D066192:Manufacturing Industry; D049268:Positron-Emission Tomography / Q000295:instrumentation*; D011849:Radioactive Tracers
chemical_list: D011849:Radioactive Tracers
keywords: Alzheimer's disease; CNS diagnostics; Neuraceq™ (florbetaben 18F); PET imaging; beta-amyloid; cardiology diagnostics; molecular imaging; oncology diagnostics